Moderna(MRNA)

搜索文档
Moderna (MRNA) Declines More Than Market: Some Information for Investors
ZACKS· 2025-09-13 06:46
Moderna (MRNA) closed at $23.51 in the latest trading session, marking a -7.4% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.05% for the day. Elsewhere, the Dow saw a downswing of 0.59%, while the tech-heavy Nasdaq appreciated by 0.45%. Shares of the biotechnology company witnessed a loss of 4.87% over the previous month, trailing the performance of the Medical sector with its gain of 7.77%, and the S&P 500's gain of 3.44%.Market participants will be closely foll ...
S&P 500 Gains and Losses Today: Warner Bros. and Paramount Extend Gains; Moderna Plunges
Investopedia· 2025-09-13 06:25
Shares of Paramount and Warner Bros. Discovery led gains on the S&P 500 Friday on speculation about a deal. Erik McGregor / LightRocket / Getty Images Close Key Takeaways Shares of two entertainment giants pushed higher for a second straight day as investors weighed the possibility of a takeover bid, while vaccine makers came under pressure following a report that health officials from the Trump administration seek to link COVID-19 vaccines with child deaths. Major U.S. equities indexes were mixed as invest ...
Pfizer, Moderna shares plunge on report that Trump officials plan to link 25 child deaths to COVID vaccine
New York Post· 2025-09-13 04:46
Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to link the deaths of 25 children to COVID vaccines.Trump health officials plan to include the claim in a presentation next week to a panel of advisors to the CDC that is considering new COVID vaccine recommendations, which can impact access to the shots and whether they’re free, according to the Washington Post.Those deaths were seemingly gathered from information submitted to the govern ...
COVID vaccine names take a hit after report of child deaths CDC presentation
Seeking Alpha· 2025-09-13 02:45
Companies that manufacture authorized COVID-19 shots are down significantly following word that a closely watched CDC vaccines advisory committee meeting next week will receive a presentation tying the vaccines to the deaths of 25 children. Moderna (NASDAQ:MRNA), Pfizer ( ...
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
CNBC· 2025-09-13 00:21
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Shares of Pfizer and Moderna fell on Friday after a report that Trump administration health officials plan to link Covid vaccines to the deaths of 25 children. The report from the Washington Post said officials plan to include the claim in a presentation next week to a key vaccine panel that advises the Centers for Disease Control and Prevention. That committee play ...
Trump officials to link child deaths to covid shots, according to reports
Youtube· 2025-09-13 00:18
We do have a news alert today on COVID vaccines and for that we'll turn back to Angelica Peebles. Hi Angelica. Hey Carl.Well the Washington Post is reporting that Trump health officials plan to link coronavirus vaccines to the deaths of 25 children and that is that comes as next week this um the CDC advisers on vaccines will weigh how those co vaccines should be used going forward. This has obviously been a very contentious issue and the Washington Post is citing people familiar with this. We of course have ...
Moderna、辉瑞、BioNTech SE短线下挫,跌至盘中低点
每日经济新闻· 2025-09-12 23:52
(文章来源:每日经济新闻) 每经AI快讯,9月12日,Moderna、辉瑞、BioNTech SE短线下挫,跌至盘中低点。 ...
Gilead, Moderna to see upside if RFK Jr. leaves HHS: RBC
Seeking Alpha· 2025-09-11 03:54
As HHS Secretary Robert F. Kennedy Jr. continues to fend off criticism of his leadership and decisions at the agency, if he were to leave the post, Gilead Sciences (NASDAQ:GILD), Moderna (NASDAQ:MRNA), and Biohaven (NYSE: ...
Moderna, Inc. (MRNA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Seeking Alpha· 2025-09-09 01:14
PresentationTerence FlynnEquity Analyst All right. Great. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's large-cap U.S. biopharma analyst. I'm very pleased to be hosting Moderna. We have Stéphane Bancel, who's the company's CEO. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. Stephane, thank you so much for joining ...